Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea
Clinical trials sponsored by Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea, explained in plain language.
-
Chemo-Free hope: new pill and antibody combo targets Slow-Growing lymphoma
Disease control Recruiting nowThis study tests a new combination of two drugs (pirtobrutinib and rituximab) as a first treatment for people with a slow-growing form of mantle cell lymphoma, a type of blood cancer. The goal is to see if this drug pair can shrink tumors without the need for standard chemotherap…
Phase: PHASE2 • Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New hope for lymphoma patients: CAR T-Cell therapy targets late relapses
Disease control Recruiting nowThis study tests a treatment called axicabtagene ciloleucel (a CAR T-cell therapy) in 45 adults whose diffuse large B-cell lymphoma has come back after a long period. The goal is to see if this therapy can make the cancer disappear on scans at 3 months. Participants receive one i…
Phase: PHASE2 • Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea • Aim: Disease control
Last updated May 26, 2026 05:04 UTC